TELA Bio, Inc. Increase (Decrease) in Accounts Receivable
TELA Bio, Inc. (TELA) reported Increase (Decrease) in Accounts Receivable of -$682.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-11
- TELA Bio, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$89.00K, a 116.70% decline year-over-year.
- TELA Bio, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$593.00K, a 247.51% decline year-over-year.
- TELA Bio, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$932.00K.
- TELA Bio, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $107.00K, a 94.67% decline year-over-year.
- TELA Bio, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $110.00K, a 85.56% decline from fiscal 2024.
- TELA Bio, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $762.00K, a 75.08% decline from fiscal 2023.
- TELA Bio, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $3.06M, a 26.31% increase from fiscal 2022.
- TELA Bio, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $2.42M, a 55.89% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$89.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | -$682.00K 10-Q · filed 2026-08-11 | -$1.61M derived: sum of 3 quarters · filed 2026-08-11 | -$1.51M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | -$593.00K 10-Q · filed 2026-05-13 | -$1.52M derived: sum of 2 quarters · filed 2026-05-13 | -$1.42M derived: sum of 3 quarters · filed 2026-05-13 | -$885.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | -$932.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$825.00K derived: sum of 2 quarters · filed 2026-03-25 | -$292.00K derived: sum of 3 quarters · filed 2026-08-11 | $110.00K 10-K · filed 2026-03-25 |
| 2025-09-30 | $107.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $640.00K derived: sum of 2 quarters · filed 2026-08-11 | $1.04M 10-Q · filed 2025-11-14 | $59.00K derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $533.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $935.00K 10-Q · filed 2026-08-11 | -$48.00K derived: sum of 3 quarters · filed 2026-08-11 | $1.96M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $402.00K 10-Q · filed 2026-05-13 | -$581.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.43M derived: sum of 3 quarters · filed 2026-05-13 | $930.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.02M derived: sum of 2 quarters · filed 2026-03-25 | $528.00K derived: sum of 3 quarters · filed 2026-03-25 | $762.00K 10-K · filed 2026-03-25 |
| 2024-09-30 | $2.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $1.51M derived: sum of 2 quarters · filed 2025-11-14 | $1.75M 10-Q · filed 2025-11-14 | $3.35M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-06-30 | -$497.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$263.00K 10-Q · filed 2025-08-11 | $1.34M derived: sum of 3 quarters · filed 2026-03-25 | $1.58M derived: sum of 4 quarters · filed 2026-03-25 |
| 2024-03-31 | $234.00K 10-Q · filed 2025-05-08 | $1.84M derived: sum of 2 quarters · filed 2026-03-25 | $2.07M derived: sum of 3 quarters · filed 2026-03-25 | $3.27M derived: sum of 4 quarters · filed 2026-03-25 |
| 2023-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.84M derived: sum of 2 quarters · filed 2026-03-25 | $3.04M derived: sum of 3 quarters · filed 2026-03-25 | $3.06M 10-K · filed 2026-03-25 |
| 2023-09-30 | $237.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $1.44M derived: sum of 2 quarters · filed 2024-11-08 | $1.46M 10-Q · filed 2024-11-08 | $2.35M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $1.22M 10-Q · filed 2024-08-13 | $2.11M derived: sum of 3 quarters · filed 2025-03-21 | $2.52M derived: sum of 4 quarters · filed 2025-03-21 |
| 2023-03-31 | $18.00K 10-Q · filed 2024-05-10 | $908.00K derived: sum of 2 quarters · filed 2025-03-21 | $1.32M derived: sum of 3 quarters · filed 2025-03-21 | $2.35M derived: sum of 4 quarters · filed 2025-03-21 |
| 2022-12-31 | $890.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | $1.31M derived: sum of 2 quarters · filed 2025-03-21 | $2.34M derived: sum of 3 quarters · filed 2025-03-21 | $2.42M 10-K · filed 2025-03-21 |
| 2022-09-30 | $416.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $1.45M derived: sum of 2 quarters · filed 2023-11-13 | $1.53M 10-Q · filed 2023-11-13 | $2.19M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-06-30 | $1.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $1.11M 10-Q · filed 2023-08-10 | $1.77M derived: sum of 3 quarters · filed 2024-03-22 | $1.81M derived: sum of 4 quarters · filed 2024-03-22 |
| 2022-03-31 | $85.00K 10-Q · filed 2023-05-11 | $742.00K derived: sum of 2 quarters · filed 2024-03-22 | $776.00K derived: sum of 3 quarters · filed 2024-03-22 | $1.53M derived: sum of 4 quarters · filed 2024-03-22 |
| 2021-12-31 | $657.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $691.00K derived: sum of 2 quarters · filed 2024-03-22 | $1.44M derived: sum of 3 quarters · filed 2024-03-22 | $1.55M 10-K · filed 2024-03-22 |
| 2021-09-30 | $34.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $784.00K derived: sum of 2 quarters · filed 2022-11-10 | $896.00K 10-Q · filed 2022-11-10 | $937.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-06-30 | $750.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $862.00K 10-Q · filed 2022-08-11 | $903.00K derived: sum of 3 quarters · filed 2023-03-23 | $951.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-03-31 | $112.00K 10-Q · filed 2022-05-11 | $153.00K derived: sum of 2 quarters · filed 2023-03-23 | $201.00K derived: sum of 3 quarters · filed 2023-03-23 | $744.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2020-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $89.00K derived: sum of 2 quarters · filed 2023-03-23 | $632.00K derived: sum of 3 quarters · filed 2023-03-23 | -$149.00K 10-K · filed 2023-03-23 |
| 2020-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $591.00K derived: sum of 2 quarters · filed 2021-11-12 | -$190.00K 10-Q · filed 2021-11-12 | $355.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-06-30 | $543.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$238.00K 10-Q · filed 2021-08-12 | $307.00K derived: sum of 3 quarters · filed 2022-03-23 | $691.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2020-03-31 | -$781.00K 10-Q · filed 2021-05-14 | -$236.00K derived: sum of 2 quarters · filed 2022-03-23 | $148.00K derived: sum of 3 quarters · filed 2022-03-23 | $168.00K derived: sum of 4 quarters · filed 2022-03-23 |
| 2019-12-31 | $545.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $929.00K derived: sum of 2 quarters · filed 2022-03-23 | $949.00K derived: sum of 3 quarters · filed 2022-03-23 | $1.53M 10-K · filed 2022-03-23 |
| 2019-09-30 | $384.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $404.00K derived: sum of 2 quarters · filed 2020-11-12 | $983.00K 10-Q · filed 2020-11-12 | $1.05M derived: sum of 4 quarters · filed 2021-03-25 |
| 2019-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $599.00K 10-Q · filed 2020-08-13 | $665.00K derived: sum of 3 quarters · filed 2021-03-25 | |
| 2019-03-31 | $579.00K 10-Q · filed 2020-05-15 | $645.00K derived: sum of 2 quarters · filed 2021-03-25 | ||
| 2018-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $541.00K 10-K · filed 2021-03-25 | ||
| 2018-09-30 | $475.00K 10-Q · filed 2019-12-18 | |||
| 2017-12-31 | $578.00K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |